The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization

Ellen R Klinkert, Frank J. Broekmans, Frank J M Broekmans, Caspar W. N. Looman, J. Dik F. Habbema, Egbert R. te Velde
Fertility and sterility · 2005 · vol. 83(3) , pp. 811–814 · doi:10.1016/j.fertnstert.2004.11.005 · PMID:15749527 · W2105596856
Observational OA: bronze CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study compared the predictive value of antral follicle count versus basal follicle-stimulating hormone for IVF success in older women, finding antral follicle count to be a superior marker.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This observational study shows that the antral follicle count is a better predictor of ongoing pregnancy in IVF patients aged >38 years of age than is basal FSH. Patients aged <44 years with a normal antral follicle count still have acceptable pregnancy rates after IVF and therefore deserve treatment.

My notes (saved in your browser only)

MeSH descriptors

Cell Count Fertilization in Vitro Follicle Stimulating Hormone Ovarian Follicle Pregnancy Rate Adult Biomarkers Cell Count Female Follicle Stimulating Hormone Humans Middle Aged Ovarian Follicle Predictive Value of Tests Pregnancy Prognosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (1)

References (23)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:04.870308+00:00
License: CC0 · commercial use OK